Saint Anne's Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Fall River MA United States

Organization Overview

First Clinical Trial
1995
NCT00116220
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

CH Sainte-Anne, Paris, France

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Endometrial Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 3)

Stroke (Phase 1)

Uterine Cervical Neoplasms (Phase 2)

Vaginal Neoplasms (Phase 2)

Vulvar Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6